|
|
|
|
Vol. 9, Issue 8, 2081-2092, August 1998


and
§
* H. Lee Moffitt Cancer Center and Research Institute, Tampa,
Florida 33612; and Departments of
Medical Microbiology
and Immunology and
Biochemistry and Molecular Biology,
University of South Florida, Tampa, Florida 33612
| |
ABSTRACT |
|---|
|
|
|---|
We report that cyclin D3/cdk4 kinase activity is regulated by p27kip1 in BALB/c 3T3 cells. The association of p27kip1 was found to result in inhibition of cyclin D3 activity as measured by immune complex kinase assays utilizing cyclin D3-specific antibodies. The ternary p27kip1/cyclin D3/cdk4 complexes do exhibit kinase activity when measured in immune complex kinase assays utilizing p27kip1-specific antibodies. The association of p27kip1 with cyclin D3 was highest in quiescent cells and declined upon mitogenic stimulation, concomitantly with declines in the total level of p27kip1 protein. The decline in this association could be elicited by PDGF treatment alone; this was not sufficient, however, for activation of cyclin D3 activity, which also required the presence of factors in platelet-poor plasma in the culturing medium. Unlike cyclin D3 activity, which was detected only in growing cells, p27kip1 kinase activity was present throughout the cell cycle. Since we found that the p27kip1 activity was dependent on cyclin D3 and cdk4, we compared the substrate specificity of the active ternary complex containing p27kip1 and the active cyclin D3 lacking p27kip1 by tryptic phosphopeptide mapping of GST-Rb phosphorylated in vitro and also by comparing the relative phosphorylation activity toward a panel of peptide substrates. We found that ternary p27kip1/cyclin D3/cdk4 complexes exhibited a different specificity than the active binary cyclin D3/cdk4 complexes, suggesting that p27kip1 has the capacity to both inhibit cyclin D/cdk4 activity as well as to modulate cyclin D3/cdk4 activity by altering its substrate preference.
| |
INTRODUCTION |
|---|
|
|
|---|
Two families of proteins play major roles in the regulation of the
cell cycle (Roberts, 1993
; Morgan, 1995
; Sherr, 1996
; Wuarin and Nurse,
1996
). One family, the cdk, exerts control on downstream processes by
phosphorylating selected proteins, such as Rb family members, on serine
and threonine residues (Morgan, 1995
). The other family consists of
specialized regulatory proteins, cyclins, that bind to cdk molecules
and modulate their activity to phosphorylate appropriate target
proteins (Swenson et al., 1986
; Hagan et al., 1988
; Booher et al., 1989
; Draetta et al., 1989
;
Hadwiger et al., 1989
; Moreno et al., 1989
). The
catalytic activity of monomeric cdk subunits is almost undetectable,
and the pathway to its formation requires, as a first step, the binding
of a cyclin subunit (Solomon et al., 1990
). While the
resulting binary cyclin/cdk complex is functionally competent, its
activity is still subject to both positive and negative control.
Maximal activity is attained only after phosphorylation of a conserved
threonine residue covering the ATP-binding pocket on the catalytic
subunit (Ducommun et al., 1991
; Gould et al.,
1991
). This phosphorylation is performed by a constitutive cellular
kinase activity, cdk-activating kinase (CAK), itself a cyclin/cdk
complex (Poon et al., 1993
; Solomon et al., 1993
;
Fisher and Morgan, 1994
). In addition, cdk activity is also subject to
negative control by two mechanisms: binding of inhibitory subunits and
phosphorylation on an amino-terminal tyrosine residue (Picard et
al., 1989
; Pondaven et al., 1990
). The cdk-inhibitory
proteins are collectively called CKIs (Elledge and Harper, 1994
; Sherr
and Roberts, 1995
), of which seven have been identified to date.
Both primary sequence homology and cdk target specificity indicate CKIs
fall into two groups, the Kip/Cip family and the Ink4 family. Unlike
the members of the Ink4 family, which are able to inhibit only
cdk4/cdk6 activity, the members of the Kip/Cip family are able to
exhibit inhibitory activity with all cdk complexes (Xiong et
al., 1993
; Harper et al., 1995
; Matsuoka et
al., 1995
). This latter group is currently composed of three
members: p2 1Cip (Harper et al., 1993
; Xiong
et al., 1993
), p27kip1 (Hengst et
al., 1994
; Polyak et al., 1994b
; Toyoshima and Hunter, 1994
), and p57 (Lee et al., 1995
; Matsuoka et
al., 1995
). The earliest known inhibitors, p21Cip1 and
p27kip1, are also the most extensively studied and have
been linked to growth arrest brought about through a number of
different environmental signals. Conditions that promote DNA damage or
otherwise cause an induction of p53 have almost invariably been
demonstrated to result in the induction of p21Cip1
(el-Deiry et al., 1993
; Dulic et al., 1994
),
whereas conditions such as high cell density, TGF-
growth
inhibition, and serum withdrawal have been associated with induction of
p27kip1 (Polyak et al., 1994a
; Toyoshima and
Hunter, 1994
; Agrawal et al., 1995
). Sequence comparisons
between p27kip1 and p21Cip1 revealed a region
of identity in the N-terminal region of each protein that contains the
motif responsible for its inhibitory activity (Nakanishi et
al., 1995
). In addition to direct inhibition of catalytic
activity, association of p27kip1 with either cdk2 or cdk4
complexes can block their CAK-mediated phosphorylation (Matsuoka
et al., 1994
). Overexpression of p27kip1 was
found to cause G1 arrest (Polyak et al., 1994b
;
Toyoshima and Hunter, 1994
), and antisense inhibition of
p27kip1 expression prevented cell cycle exit in response to
mitogen depletion (Coats et al., 1996
; Rivard et
al., 1996
), consistent with its proposed role as a negative
regulator of cell cycle progression in vivo. Unlike
p21Cip1, p27kip1 protein levels either remain
relatively constant in cycling cells or are high in quiescent cells and
decreased in growing cells (Nourse et al., 1994
; Toyoshima
and Hunter, 1994
; Agrawal et al., 1995
). Thus, in some cell
types, p27kip1 is an essential component of the pathway
that connects mitogenic signals to the cell cycle at the restriction
point and may be the primary CKI protein responsible for producing an
inhibitory threshold for activation of cyclin/cdk complexes in
quiescent cells.
It is widely agreed that cyclin D1 plays an important role in
sequestering p27kip1 during the G1 phase,
allowing cyclin E/cdk2 to become active and thus permitting entry into
S phase (Polyak et al., 1994a
). Although cdk activities are
observed during G1, the role of p27kip1
inhibition of cyclin D/cdk4 activity in cell cycle regulation remains
to be clarified. Recently published data have led to several different
conclusions concerning the effect of p27kip1 on D type
cyclin activity including: 1) p27kip1-associated cyclin
D/cdk4 is active (Reynisdottir and Massague, 1997
), 2)
p27kip1-associated cyclin D complex is not active (Polyak
et al., 1994b
; Toyoshima and Hunter, 1994
; LaBaer et
al., 1997
), and 3) p27kip1 must be removed before the
cyclin D/cdk can be activated by CAK (Kato et al., 1997
).
Moreover, it has recently been demonstrated that while
p27kip1 readily inhibits cyclin/cdk2 activity, it requires
multiple p27kip1 molecules to inhibit an active cyclin
D/cdk4 complex. In contrast to its roles as an inhibitor of cdk,
p27kip1-immune complexes isolated from MANCA cells, a human
Burkitts lymphoma cell line, were reported to contain an Rb kinase
activity (Soos et al., 1996
). The
p27kip1-specific activity was incapable of phosphorylating
histone H1 and was removed by depletion of cdk6, characteristics
suggesting that it was a cyclin D-dependent activity.
Furthermore, p27kip1 complexes prepared from primary mouse
keratinocytes stimulated to undergo differentiation contained an Rb
kinase activity that was dependent on cyclin D3/cdk4 (Hauser et
al., 1997
). Clearly, the mechanisms whereby cyclin D/cdk complexes
are activated and the role that p27kip1 may play on cyclin
D/cdk activity, such as to inhibit this activity or to bring about a Rb
kinase in association with cyclin D/cdk4/p27kip1 complexes,
has not been elucidated.
The physiological role of p27kip1, in most cases, has been
linked to inhibition of cyclin E/cdk2, and the association of
p27kip1 with cyclin D/cdk4 is believed to be required only
to lower the inhibitory threshold for cyclin E/cdk2 activation. This
idea is strongly supported by numerous studies but does not exclude the possibility that a ternary cyclin D/cdk4/p27kip1 complex
may be physiologically distinct from a binary complex lacking
p27kip. Since it has been previously demonstrated that
cyclin D3/cdk4 activity also appears during G1 traverse in
BALB/c 3T3 fibroblasts (Dong et al., 1998
) and that cyclin
D3 is bound to p27kip1 complexes in quiescent cells
(Agrawal et al., 1996
), we have examined the possibility
that cyclin D3 activity may be subject to inhibition by
p27kip1 in this cell line. Our results indicate that
p27kip1 is removed from cyclin D3 complexes after mitogenic
stimulation with PDGF, which may be necessary but is not sufficient for
cyclin D3/cdk4 activation. In addition, we have found that the
association of p27kip1 with cyclin D3 in quiescent cells
also gives rise to a kinase activity that may be detected in
p27kip1-immune complexes. By comparing the phosphorylation
specificity of ternary p27kip1/cyclin D3/cdk4 complexes and
binary complexes lacking p27kip1, we demonstrate that the
addition of p27kip1 results in an alteration of substrate
specificity.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture
BALB/c 3T3 fibroblasts (clone A31) were maintained in an
incubator with a humidified atmosphere (5% CO2, 95% air)
at 37°C. Experimental cultures were grown to confluence in 100-mm
Petri dishes using DMEM supplemented with 10% calf serum (CS), 4 mM L-glutamine, 50 U/ml penicillin, and 50 µg/ml
streptomycin. Quiescent cultures were stimulated 2-3 d after
density-arrest by the addition of fresh medium (DMEM) containing 10 ng/ml PDGF-BB, and 10% CS (Agrawal et al., 1995
;
Winston et al., 1996
).
Reagents, Recombinant Plasmids, and Antibodies
Biological buffers, detergents, and chemicals (except for those
indicated below) were from Sigma Chemical (St. Louis, MO) or Fisher
Scientific (Pittsburgh, PA). Cell culture medium, antibiotics, and
protein A-agarose beads were from Life Technologies (Gaithersburg, MD),
and PDGF-BB was from BioSource (Camarillo, CA). Nitrocellulose paper
and reagents for SDS-PAGE were from Bio-Rad (Hercules, CA). Rabbit
anti-mouse HRP, ECL reagents, and radioisotopes were from Amersham
(Arlington Heights, IL). Autoradiographic film was from Eastman Kodak
(Rochester, NY). A plasmid encoding GST-Rb 379-928 was obtained from
Doug Cress (H. Lee Moffitt Cancer Center and Research Institute). The
cyclin D1 (72-13G) and D3 (C-16) antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA). The cdk4 antibody was raised against
C-terminal polypeptide of mouse cdk4. The cyclin E antibody was raised
against C-terminal polypeptide of mouse cyclin E. The
p27kip1 antibody was raised against His6-kip fusion
protein (Agrawal et al., 1996
).
Preparation of Mouse Primary Fibroblasts (MPFs)
p27+/
mice were the gift of Dr. Andrew Koff
(Memorial Sloan-Kettering Cancer Center, New York, NY) (Kiyokawa
et al., 1996
). Further intercross of the p27+/
mice produced both p27
/
and p27+/
offspring. To prepare primary dermal fibroblasts, the bottom layer of
skin was obtained from newborn mice, transferred to fresh sterile PBS
containing 0.1% trypsin, and stirred in a small beaker for 30 min at
room temperature. The PBS containing the subcutaneous tissue was
filtrated through three layers of sterile abrasive cloth. The cells in
the filtrate were grown in DMEM supplemented with 10% CS.
Preparation of Cell Extracts
Cultures were rinsed twice in ice-cold PBS, harvested by
scraping, and collected by centrifugation at 12,000 × g for 6 s. The pellets were resuspended in lysis buffer
(50 mM HEPES [pH 7.5], 100 mM NaCl, 2 mM EDTA, 0.5% NP-40, 10%
Glycerol, 0.1 mM sodium orthovanadate, 0.1 mM PMSF, 2.5 µg/ml
leupeptin, and 1 mM DTT), vortexed vigorously, and incubated on ice for
30 min. After centrifugation at 14,000 × g for 3 min,
the supernatant was transferred into fresh tubes, and then stored at
70°C.
Immunological Assays
Immunoprecipitation was performed using 40 µg of total proteins from cell extracts. Specific antisera were incubated with protein A-agarose beads in 250 µl of the lysis buffer described above at 4°C for 2 h while shaking. The antibody-linked beads were washed once with lysis buffer, mixed with appropriate cell extracts, and incubated for 2 h at 4°C. For subsequent immunoblotting analysis, complexes bound to protein A-agarose were washed twice with lysis buffer, resuspended in 15 µl of SDS-PAGE loading buffer, heated to 95°C for 5 min, separated by SDS-PAGE, and transferred to a nitrocellulose membrane. The blots were incubated with the primary antibody for 1 h followed by a 1-h incubation with a secondary antibody. The bound antibodies were visualized using the ECL detection system (Amersham) according to the manufacturer's instructions.
In Vitro Kinase Assay Using Purified Fusion Proteins
Specific antiserum (2 µl) and 30 µl of 25% protein
A-agarose beads were added to 250 µl of lysis buffer, and the mixture
was rocked for 2 h at 4°C, followed by the addition of 40 µg
of total protein from cell extracts and an additional 2 h of
mixing. Immune complexes were collected by centrifugation at
14,000 × g for 1 min and washed twice with lysis
buffer, once with 2 × kinase reaction buffer (50 mM HEPES [pH
7.5], 10 mM MgCl2, 5 mM MnCl2, 10 mM DTT), resuspended in 8 µl of 1× kinase reaction buffer containing 10 µCi
[
-32P]-ATP, 10 µM cold ATP, and 1 µg of GST-pRb.
The mixture was incubated at 30°C for 30 min, resuspended in 10 µl
of SDS-PAGE loading buffer, heated to 95°C for 5 min, and separated
on an 11% SDS-polyacrylamide gel. Phosphorylated proteins were
visualized by exposure to Kodak XAR-5 x-ray film for 30 min to 10 h and quantitated by exposure on a PhosphorImager (Molecular Dynamics,
Sunnyvale, CA).
In Vitro Kinase Assay with Synthetic Peptide Substrates
For in vitro kinase assay using synthetic peptides, substrate
peptides derived from the pRb sequence and previously demonstrated to
reflect cdk4 phosphorylation sites were synthesized and purified by
HPLC at Genemed Synthesis (South San Francisco, CA). The nomenclature utilized in this report corresponds to that previously reported (Kitagawa et al., 1996
).
Immune complexes were obtained as described above and resuspended in 8 µl of 1× kinase reaction buffer containing 10 µCi
[
-32P]-ATP, 10 µM cold ATP, and 1 µg of synthetic
peptide. The mixture was incubated at 30°C for 30 min, added with 10 µl of 2× loading buffer, heated to 95°C for 5 min, and separated
on a 16.5% T/6% C tricine-SDS-polyacrylamide gel. Tricine-SDS-PAGE
was carried out essentially as described (Schagger et al.,
1990
). A three-layer gel (stacking, 4%; spacing, 10%; and separating,
16.5%) was constructed, and phosphorylated protein was loaded and
electrophoresed at 140 V until the tracking dye was within 3 cm of the
bottom of the gel. The dye line was cut, and the remainder of the gel
was fixed in a buffer containing 10% methanol and 10% acetic acid for
30 min. Phosphorylated protein was visualized by exposure to Kodak XAR-5 x-ray film in a Life Technologies magnetic film cassette for
2-24 h and quantitated by exposure on a PhosphorImager (Molecular Dynamics).
Tryptic Phosphopeptide Mapping
To examine the phosphorylation specificity of various immune
complexes, GST-Rb was phosphorylated as described above in vitro. After
32P-labeled samples were separated on an 11%
SDS-polyacrylamide gel, the gel was dried, and the protein bands were
cut out from individual lanes using a single-edge razor blade. The
pieces of gel were placed in a microcentrifuge tube and incubated in
400 µl freshly prepared 50 mM ammonium bicarbonate, pH 7.4, for 5 min
at room temperature. After removal of the paper backing, the pieces of
gel were ground until they could pass through a disposable tip of a
200-µl adjustable pipette. To elute radioactive proteins from gel, 40 µl
-mercaptoethanol and 8 µl 10% SDS were added to the gel
pieces, followed by boiling for 3 min and incubating for 90 min at room
temperature on a shaker. After centrifugation, the supernatant was
transferred to a new tube. Protein was recovered by adding 20 µg
boiled RNase A and 250 µl ice-cold 100% trichloroacetic acid
to the supernatant, followed by incubating the mixture for 1 h on
ice. The precipitates were washed twice with 96% ice-cold ethanol,
air-dried, resuspended in 50 µl of 50 mM ammonium bicarbonate, pH
7.9, and digested for 10 h with 10 µg trypsin (Boehringer
Mannheim, Mannheim, Germany).
Peptides were separated on cellulose TLC plates (Merck, Darmstadt, Germany) using electrophoresis in formic acid, glacial acetic acid, and deionized water (50:156:1794/2 l) as first dimension and chromatography in butanol, pyridine, glacial acetic acid, and deionized water (75:50:15:60/200 ml) as second dimension. The plates were allowed to dry in a fume hood overnight, and the phosphopeptides were visualized by exposure to a phosphoimaging screen.
| |
RESULTS |
|---|
|
|
|---|
Cyclin D3 Activity Is Accompanied by a Reduced Association with p27kip1
It has been demonstrated previously that cyclin D3/cdk4 kinase
activity appears after density-arrested BALB/c 3T3 cultures are
stimulated to undergo cell cycle traverse, 12-18 h after mitogenic stimulation (Dong et al., 1998
). We determined whether this
activity was present in continuously cycling cells and its fate upon
density-dependent growth inhibition (Figure
1A). It is clear from these data that cyclin D3 kinase activity is present in growing cells and
down-regulated upon growth inhibition and then reappears after
mitogenic stimulation. The cyclin D3 protein level, however, did not
fluctuate in a proportional manner and appeared to remain relatively
constant throughout the course of these growth transitions (Figure 1B).
This observation suggested the cyclin D3-associated activity was,
therefore, controlled at a level other than cyclin accumulation.
Although it has been established that the level of cdk4 protein also
remains constant in this cell line, the levels of p27kip1
are known to increase during density-dependent growth arrest (Figure 1C
and Agrawal et al., 1995
, 1996
), suggesting that the association of p27kip1 with cyclin D3/cdk4 may have
contributed to the loss of activity observed in Figure 1A.
|
We also analyzed the level of cyclin D3 protein and its associated cdk
and CKI subunits more closely in populations synchronized by density
arrest and then mitogenically stimulated. As with the experiment shown
in Figure 1, synchronized populations did not exhibit a significant
change in the level of cyclin D3 protein during cell cycle traverse
(Figure 2A), although the level of cyclin
D3 activity was significantly elevated between 12 and 18 h (Figure
2B). This pattern is in striking contrast to that observed for cyclin
D1 kinase activity, which increases concomitantly with an increase in
cyclin D1 protein during serum-dependent cell cycle traverse (Agrawal
et al., 1996
; Winston et al., 1996
). To examine the possibility that cyclin D3 activity was dependent on cdk4, the
catalytic subunit responsible for cyclin D1 activity in murine fibroblasts, we prepared cell extracts that were depleted of cdk4 (Figure 2C). We then compared the mock depleted and cdk4-depleted extracts for the presence of cdk4 kinase activity and cyclin D3 kinase
activity (Figure 2D). The data revealed that the cyclin D3 activity was
quantitatively removed by immunodepletion of cdk4, demonstrating that
the activity observed in Figure 2B reflected cyclin D3/cdk4 complexes.
|
It has recently been demonstrated, however, that ectopic expression of
both cyclin D1 and cdk4 does not result in the formation of an active
complex primarily as a result of a failure of the subunits to associate
in the absence of serum factors (Cheng et al., 1998
). To
examine the possibility that the lack of cyclin D3-associated activity
was due to the absence of a catalytic subunit, the in vivo association
of cyclin D3 with cdk4 was evaluated in extracts derived from quiescent
cells and those mitogenically stimulated for various lengths of time.
Figure 3A reveals that the amount of cdk4
protein remained constant throughout the course of the experiment. In
addition, examination of cyclin D3-immune complexes for cdk4 protein
revealed the amount of cdk4 associated with cyclin D3 also remained
proportional throughout the cell cycle (Figure 3B), indicating that the
increased cyclin D3-associated activity was not the result of increased
amount of binary complexes. Since the total level of
p27kip1 was inversely proportional to the level of cyclin
D3 activity, we also determined the amount of p27kip1
associated with cyclin D3. The results, shown in Figure 3, C and D,
revealed that cyclin D3-associated p27kip1 declined upon
mitogenic stimulation, reaching a minimum in the interval in which
cyclin D3 activity appeared. Thus, the amount of p27kip1
associated with cyclin D3 was inversely proportional to the cyclin D3
Rb kinase activity. Taken together, the data in Figures 1-3 support the hypothesis that p27kip1 plays a role in the regulation
of the activity of cyclin D3/cdk4.
|
PDGF does not bring about cell cycle traverse of BALB/c-3T3 cells
unless growth factors found in platelet-poor plasma (PPP) are
also present; however, PDGF does bring about a reduction in the amount
of p27kip1 (Agrawal et al., 1996
; Winston
et al., 1996
). To determine whether PDGF was sufficient to
cause a reduction in the amount of p27kip1 associated with
cyclin D3, we examined cultures treated for 18 h with PDGF, 10%
PPP, or PDGF + 10% PPP for the level of cdk4 and p27kip1.
All three treatments resulted in cultures that exhibited similar levels
of total cdk4 protein and cyclin D3-associated cdk4 (Figure 4A), clearly indicating the absence of
activity was not the result of a failure to assemble cyclin D3/cdk4
complexes. In addition, cultures stimulated with PDGF, either in the
presence or in the absence of PPP, exhibited a reduced level of
p27kip1 protein (Figure 4B). Consistent with this
reduction, the portion of cyclin D3 protein that was not complexed to
p27kip1, as determined by Western blotting of cell extracts
that had been immunodepleted of p27kip1 (Figure 4C),
differed dramatically between quiescent and mitogenically stimulated
cells. In extracts prepared from quiescent cells and cells treated with
PPP alone, cyclin D3 was quantitatively removed by immunodepletion of
p27kip1, while similar levels of cyclin D3 were present in
p27kip1-immunodepleted extracts prepared from cells treated
with PDGF or with PDGF + 10% PPP. Cyclin D3 activity, however, was
observed only in cultures treated with PDGF in the presence of PPP
(Figure 4D), supporting the hypothesis that the removal of
p27kip1 from the cyclin D3 complex is required, but not
sufficient, for activation of the cyclin D3/cdk4 Rb kinase.
Thus, the induction of cyclin D3- associated Rb kinase activity during
the mitogenic stimulation of BALB/c 3T3 cells appears to result from a
two-step activation. The first step is the removal of
p27kip1 from the ternary p27kip1/cyclin D3/cdk4
complex, which is under the control of PDGF. The second step is the
activation of the cyclin D/cdk4 complex, which is dependent on the
presence of factors in PPP or regulated by traverse of the cell cycle.
|
p27kip1-associated Rb Kinase Remains Elevated Throughout the Cell Cycle
Recently, p27kip1-immune complexes were shown to have
Rb-associated kinase activity in hematopoetic (Soos et al.,
1996
) and epithelial (Hauser et al., 1997
) cells. We
detected p27kip1-specific kinase activity in BALB/c 3T3
fibroblasts extracts by assaying p27kip1-immune complexes
for phosphotransferase activity with GST-Rb as substrate. As shown in
Figure 5A, a p27kip1 Rb
kinase was present in quiescent cells and continued to be detectable in
mitogenically stimulated cells, although this activity appeared to
decrease somewhat after 9-12 h of stimulation. To determine the cyclin
on which p27kip1 kinase activity was dependent, we
immunodepleted either cyclin D1, D2, D3, cdk4, or cyclin E and tested
the immunodepleted extracts for the presence of p27kip1 Rb
kinase activity (Figure 5B). These experiments revealed that the
p27kip1 Rb kinase was most dependent on cyclin D3 and cdk4
(Figure 5B).
|
To examine whether the dependency of p27kip1 kinase activity on cyclin D3 was periodic, p27kip1 activity was determined with or without prior cyclin D3 depletion in extracts prepared from quiescent cells and cells mitogenically stimulated for various times up to 18 h. Each extract was divided into two portions: the first utilized to measure p27kip1 Rb kinase activity (Figure 5C, lanes 1-6) and the second to measure cyclin D3 kinase activity (Figure 5C, lanes 7-12). In addition, the second group of extracts was assayed for p27kip1 activity after removal of cyclin D3 (Figure 5C, lanes 13-18). In accord with the results shown above, the Rb kinase activity associated with p27kip1 remained relatively constant, while the cyclin D3 Rb kinase activity was not observed until 12 h of mitogenic stimulation. In addition, the p27kip1 activity was uniformly removed by cyclin D3 immunodepletion throughout the cell cycle. Note that the dependence of p27kip1 activity on cyclin D3/cdk4 was observed (lanes 13-15) even though no cyclin D3 activity could be detected in cells until 12 h after stimulation (lane 13/14).
From the results presented above, it is clear that untreated cells and cells treated with PPP contained a cyclin D3 population that is entirely bound to p27kip1 since immunodepletion with p27kip1-specific antibody completely removed cyclin D3 (Figure 4C). However, cells treated with PDGF in the presence or absence of PPP had, in addition, a distinct pool of cyclin D3 that was not associated with p27kip1. Since cyclin D3 immunodepletion resulted in the removal of p27kip1-associated kinase activity, the p27kip1 Rb kinase must represent the former pool. The second pool of cyclin D3, not associated with p27kip1, is responsible for the cyclin D3 activity, since cyclin D3 activity can be recovered from p27kip1-depleted extracts prepared from stimulated cells. Because the p27kip1 Rb kinase is present and dependent on cyclin D3 in quiescent cells, when cyclin D3 kinase cannot be detected (Figure 5A), we determined whether the addition of cyclin D3 antibodies to p27kip1-immune complexes could mask the Rb kinase activity (Figure 5D). The results demonstrate that inhibition of Rb kinase activity resulted from the addition of an antibody to cyclin D3 but not from the addition of an antibody to cyclin D1 and suggest that the function of cyclin D3 in a ternary p27kip1/cyclin D3/cdk4 complex is extremely sensitive to the steric constraints imposed by antibody binding. The effect of anticyclin D3 antibody-directed inhibition was not specific for the antiserum that is shown, and similar results were also obtained with a monoclonal antibody to cyclin D3 (our unpublished observations). In addition, it is interesting to note that when recombinant p27kip1 was added to active cyclin D3/cdk4 complexes prepared from stimulated cells, the activity was greatly diminished (Figure 5E), demonstrating the active cyclin D3/cdk4 complex can be inhibited by p27kip1 in vitro.
P27KIP1 Alters the Cyclin D3/cdk4 Rb Substrate Specificity
Our data reveal that cyclin D3/ckd4-dependent kinase activity in mitogenically stimulated cells resided in two separate pools: one pool was not associated with p27kip1, and one pool clearly was associated with p27kip1. The cyclin D3/cdk4 activity that was not associated with p27kip1 could be readily immunoprecipitated and measured with an antibody to cyclin D3. The second pool of cyclin D3/cdk4 was associated with p27kip1 and did not display Rb kinase activity when immunoprecipitated or treated with antibodies to cyclin D3; however, this complex did display Rb kinase activity when prepared with an antibody to p27kip1. The data in Figure 5D indicated that the association of p27kip1 with the cyclin D3/cdk4 complex resulted in a structural alteration such that the presence of cyclin D3 antibodies inhibited kinase activity. To investigate whether p27kip1 association may have functional consequences, we sought to determine whether the association of p27kip1 with the cyclin D3/Cdk4 complex altered the in vitro substrate specificity with an Rb substrate.
Extracts prepared from density-arrested cells and from cells that had been mitogenically stimulated for 18 h were used to isolate p27kip1- and cyclin D3-immune complexes, respectively, and these complexes were used to phosphorylate Rb in vitro. The phosphorylated Rb product from each reaction was analyzed by tryptic phosphopeptide mapping to compare the sites of phosphorylation. Figure 6 shows a comparison of the phosphopeptide maps obtained with p27kip1-phosphorylated Rb (Figure 6A) and the cyclin D3-phosphorylated Rb (Figure 6B). The arrows in each panel indicate peptides that are differentially phosphorylated by the two complexes. Arrow 1 indicates a phosphopeptide that is greatly diminished in the phosphopeptide map from cyclin D3/cdk4-phosphorylated Rb, while arrow 2 indicates a phosphopeptide present in cyclin D3/cdk4-phosphorylated Rb (arrow 2) that is diminished in the Rb phosphorylated by the p27kip1/cyclin D3/cdk4 activity (Figure 6A). These data clearly demonstrate that the association of p27kip1 with the cyclin D3/cdk4 altered the phosphorylation specificity, as determined by a change in the relative level of phosphorylation at two sites. The observation that one peptide was preferentially phosphorylated by each kinase complex indicated that the alteration was indeed related to specificity and not simply a consequence of reduced activity. It is unlikely that the difference in the specificity could be explained by the presence of a minor contaminating kinase species since immunodepletion of cdk4 results in the removal of both p27kip1-associated (Figure 5B) and cyclin D3-associated (Figure 2C) activity. The differences in the phosphorylation specificity between p27kip1/cyclin D3/cdk4 and cyclin D3/cdk4 were studied further in a second type of assay utilizing peptides with sequences derived from Rb protein. Figure 7 shows the phosphorylation of these individual peptides by the two different complexes. In the active complex containing p27kip1, peptide G is utilized as a substrate more than twice as efficiently as peptide J, while in the active cyclin D3 complex (without p27kip1), peptides G and J are equally active as substrates.
|
|
Restoration of in Vitro p27kip1Rb Kinase Activity in
Fibroblasts Derived from p27kip1
/
Mice Using
Recombinant p27kip1
To test whether p27kip1 complexes containing cyclin
D3/cdk4 could be formed by the addition of recombinant
p27kip1 protein, we utilized dermal fibroblasts isolated
from newborn mice with a kip
/
phenotype (Kiyokawa
et al., 1996
). Density-arrested cultures were mitogenically
stimulated with fresh medium containing 10% CS and PDGF (10 ng/ml).
Extracts prepared from stimulated p27kip1
/
cells were
cleared of possible p27kip1 cross-reacting materials and
were then mixed with recombinant p27kip1 protein. After a
30-min incubation at 37°C, the exogenous p27kip1 protein
was recovered by immunoprecipitation and assayed for p27kip1 Rb kinase activity. The data shown in Figure
8 demonstrate that incubation of
p27kip1 in a cell extract containing active cyclin D3
complexes can result in the formation of a p27kip1 Rb
kinase activity in a cyclin D3-dependent manner.
|
| |
DISCUSSION |
|---|
|
|
|---|
The data presented in this report demonstrate the cell cycle
regulation of cdk4 activity by cyclin D3. The control of cdk4 activity
through cyclin D1 has been extensively studied (Xiong et
al., 1991
; Matsushime et al., 1992
, 1994
; Won et
al., 1992
; Baldin et al., 1993
; Quelle et
al., 1993
; Winston and Pledger, 1993
); however, there is
considerably less work on its control through the additional
D-type cyclins D2 and D3, which are also present in a
variety of cell types (Kato and Sherr, 1993
; Meyerson and Harlow, 1994
;
Polyak et al., 1994a
; Hauser et al., 1997
). We
have shown that cyclin D3 protein was present in both growing and
nongrowing BALB/c 3T3 cells, although D3-associated Rb kinase activity
was only detectable in growing cells. This observation provides a
marked contrast with cyclin D1, which is absent in quiescent cells and
accumulates upon entering the growth cycle, correlating with increased
activity (Agrawal et al., 1996
; Winston et al.,
1996
). By examining cyclin D3 complexes for the presence of catalytic
and inhibitory subunits, we have demonstrated that the periodic
activity can be explained, in part, by the accumulation of
p27kip1 in quiescent cells that binds quantitatively to
cyclin D3/cdk4 complexes. Once inactivated in this manner, removal of
p27kip1 is not sufficient to regain activity, which is
accomplished only under culture conditions that promote S-phase entry.
Curiously, while the cyclin D3/cdk4 complexes isolated from quiescent
cells do not exhibit in vitro kinase activity, the corresponding
p27kip1-immune complexes do exhibit in vitro activity.
Furthermore, this activity is dependent on cyclin D3/cdk4 and can thus
be depleted with antibodies to either protein. These data suggested
that p27kip1 may not only inhibit the cyclin D3/cdk4
complexes per se, but also modify the activity. This hypothesis was
confirmed using both a recombinant Rb substrate as well as peptide
substrates derived from Rb sequences known to be phosphorylated by
cdk4. In both types of assays, p27kip1 complexes derived
from quiescent cells and dependent on cyclin D3/cdk4 for activity were
found to exhibit different phosphorylation specificities than the
active cyclin D3/cdk4 complexes isolated from growing cells. Thus,
these data are consistent with the notion that cyclin D3/cdk4 activity
may serve dual functions during cell cycle traverse, the first in a
binary form that is present during growth and a second function in a
ternary complex with p27kip1 that modifies its substrate
specificity.
Although periodic cyclin D1 activity has been demonstrated to primarily
result from periodic cyclin D1 synthesis, it is clear from our data
that cyclin D3 is present throughout the growth cycle in BALB/c 3T3
cells. Furthermore, we have found that the association of cyclin D3
with cdk4 also remains constant and thus can explain neither the loss
of activity in quiescent cells nor the appearance of activity upon
subsequent mitogenic stimulation. In contrast, the periodic association
of p27kip1 with cyclin D3 renders this cdk inhibitor a
likely candidate for mediating regulation of cyclin D3 activity. The
Kip/Cip family of proteins was initially described as proteins capable
of inhibiting both cdk2 and cdk4 (Polyak et al., 1994b
;
Toyoshima and Hunter, 1994
). Recent studies, however, directed at a
more detailed understanding of the role of p27kip1 in
regulation of D-cyclin/cdk4 activity, have provided data
that, if not conflicting, remain to be reconciled. In accord with our results, Kato et al. (1997)
found that cyclin D1/cdk4
complexes found in serum-starved RAT-1 cells were inactive due to
associated p27kip1, primarily resulting in complexes that
did not undergo CAK-mediated cdk4 phosphorylation, a property that was
previously described for p27kip1 in vitro
(Matsuoka et al., 1994
). Furthermore, while both
p27kip1 and p21Cip1 are active in promoting the
assembly of cyclin D/cdk4 complexes, those complexes formed by
p21Cip1 resulted in complexes with kinase activity, whereas
those formed by p27kip1 did not (LaBaer et al.,
1997
). The latter observation is again consistent with the notion that
p27kip1 is a physiological inhibitor of cdk4. Other
reports, however, have questioned the ability of p27kip1 to
effect inhibition under physiological conditions, demonstrating active
cyclin D/cdk4 activity in the presence of micromolar concentrations of
p27kip1 (Blain et al., 1997
). Together, these
findings leave the role of p27kip1 in the regulation of
cyclin D/cdk4 complexes unclear. Our experiments indicate that the
amount of cyclin D3/cdk4 activity in BALB/c-3T3 cells is inversely
correlated with amount of p27kip1 bound to cyclin D3/cdk4
(Figures 1 and 2), and we demonstrated that the inhibitory effect of
p27kip1 could be observed in vitro by addition of
recombinant p27kip1 protein to cyclin D3 complexes (Figure
5E). Our data, therefore, support the hypothesis that
p27kip1 is a physiological cdk4 inhibitor, at least in the
case of cyclin D3. We note that much of the work reporting the effect
of p27kip1 on cdk4 activity has primarily utilized cyclin
D1 and cyclin D2 (Polyak et al., 1994a
; Blain et
al., 1997
; Kato et al., 1997
; LaBaer et al.,
1997
; Reynisdottir and Massague, 1997
). Thus, our results may also
indicate a difference in the specificity of p27kip1 with
respect to a particular cyclin subunit.
Previous studies showed that both PDGF and PPP are required for
stimulation of BALB/c 3T3 cells to enter the cell cycle, and our
results indicate that activation of cyclin D3/cdk4 requires both
mitogenic components. While it has been established that PDGF is
sufficient to result in a reduction of the total level of
p27kip1 (Agrawal et al., 1996
; Winston et
al., 1996
), we demonstrate here that PDGF stimulation also results
in the removal of p27kip1 from cyclin D3 complexes.
However, p27kip1-free cyclin D3/Cdk4 complexes generated by PDGF
treatment alone were not active and, therefore, we concluded that a
PPP-dependent factor(s) or cell cycle progression was required for
activating the cyclin D3/cdk4 complex. This is consistent with the
finding that CAK is required for activating cyclin D complexes after
removal of p27kip1 (Kato et al., 1997
). However,
since CAK has been shown to have constitutive activity (Matsuoka
et al., 1994
), the lack of activity in the cyclin D3/cdk4
complexes that are free of p27kip1 suggests that another
cell cycle-regulated event must be required to activity the cyclin
D3/cdk4 complex at the appropriate time within the traverse of G1.
p27kip1-associated kinase activity that could phosphorylate
pRb but not histone H1 was first described in MANCA cells, a
hematopoetic B-cell line (Soos et al., 1996
). The MANCA
p27kip1 kinase activity appeared to be dependent on cdk6,
since a cdk6-specific antibody was able to deplete 50% of the
activity. Therefore, it was proposed that
p27kip1-associated kinase activity was derived from cdk6
and that p27kip1 was incapable of inhibiting the cyclin
D/cdk6. Since cdk6 has not been found in BALB/c 3T3 mouse fibroblasts
and since there is a constant high p27kip1-associated Rb
kinase activity in the cell throughout the cell cycle, we explored the
derivation of the activity. In our experiments, more than 70% of the
p27kip1 Rb kinase activity could be depleted by cyclin
D3-specific and cdk4-specific antibodies, but was not affected by
depletion with D1, D2, or E-specific antibodies (Figure 5B). Therefore,
in BALB/c-3T3 fibroblasts, p27kip1-associated kinase
activity is derived from cyclin D3/cdk4 and not cdk6. Interestingly, in
quiescent cells we could measure kinase activity in
p27kip1-immune complexes but not in cyclin D3-immune
complexes. Further experiments indicated that the binding of a cyclin
D3-specific antibody itself partially inhibited the kinase activity of
the p27kip1 immunocomplex, suggesting that a conformational
change may occur upon the binding of p27kip1 to cyclin
D3/cdk4 (Figure 5D). It is possible that the sensitivity of the ternary
complex to inhibition by cyclin D3 antibodies could also explain the
loss of activity we observed after addition of recombinant
p27kip1 protein to cyclin D3-immune complexes, although we
note that several studies have demonstrated the inhibition of
D-cyclin-dependent cdk4 activity in assays with purified
proteins.
Because the p27kip1 Rb kinase activity did not change while
the amount of ternary complexes decreased substantially (see Figures 3
and 4), we propose that only a portion of the complex
(p27kip1/cyclin D3/cdk4) is an active kinase in quiescent
cells. This decline in the amount of ternary complexes is most likely a
reflection of the reduced level of p27kip1 that occurs
after mitogenic stimulation since the level of cdk4 and cyclin D3
remained relatively constant under these conditions. We note that these
data could also be explained by a decreased specific activity of
ternary complexes present in quiescent cells as compared with ternary
complexes present in mitogenically stimulated cells. This latter
possibility would nonetheless require an additional modification to
convert the lower-specific activity form to the higher-specific
activity form. The reaction required to activate this ternary complex
is not known and may represent a novel activation mechanism, since it
is known that CAK is unable to phosphorylate cdk4 complexes containing
p27kip1 (Matsuoka et al., 1994
).
In light of the role of p27kip1 as a growth suppressor, it might be expected that a p27kip1-associated kinase would have different characteristics than a binary cyclin D3/cdk4 complex. To address whether such a difference might be detected as an alteration in substrate specificity, we performed tryptic phosphopeptide mapping of in vitro phosphorylated Rb and also compared catalytic efficiency with a panel of peptide substrates. We demonstrated that p27kip1-associated kinase has a different substrate specificity than that of cyclin D3-dependent kinase in experiments using either an Rb substrate or peptides as substrates (Figures 6 and 7). The results from both types of experiments demonstrated an alteration in phosphorylation patterns between p27kip1/cyclin D3/cdk4 and cyclin D3/cdk4 complexes, indicating that the binding of p27kip1 can result not only in inhibition of cdk activity but also modify the target specificity.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by National Cancer Institute/National Institutes of Health grant CA-67360 and the Cortner Couch Endowed Chair for Cancer Research. We would like to acknowledge the assistance of the H. Lee Moffitt Cancer Center Flow Cytometry Core and Molecular Imaging Core. We would also like to thank Rebecca Koransky for excellent editorial assistance.
| |
FOOTNOTES |
|---|
§ Corresponding author.
| |
REFERENCES |
|---|
|
|
|---|